AIM Vaccine Co (HKSE:06660) EBIT per Share : HK$-0.20 (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is AIM Vaccine Co EBIT per Share?

AIM Vaccine Co's EBIT per Share for the six months ended in Dec. 2024 was HK$-0.09. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.20.

During the past 3 years, the average EBIT per Share Growth Rate was 32.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for AIM Vaccine Co's EBIT per Share or its related term are showing as below:

HKSE:06660' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 32.7 Med: 32.7 Max: 32.7
Current: 32.7

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of AIM Vaccine Co was 32.70% per year. The lowest was 32.70% per year. And the median was 32.70% per year.

HKSE:06660's 3-Year EBIT Growth Rate is ranked better than
78.17% of 1237 companies
in the Biotechnology industry
Industry Median: 8.1 vs HKSE:06660: 32.70

AIM Vaccine Co's EBIT for the six months ended in Dec. 2024 was HK$-107 Mil.

AIM Vaccine Co EBIT per Share Historical Data

The historical data trend for AIM Vaccine Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AIM Vaccine Co EBIT per Share Chart

AIM Vaccine Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

0.49

-0.60

-0.38

-2.01

-0.20

AIM Vaccine Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBIT per Share	Get a 7-Day Free Trial				-0.26	-0.26	-1.75	-0.12	-0.09

AIM Vaccine Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

AIM Vaccine Co's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-245.481	/	1211.063
=	-0.20

AIM Vaccine Co's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-107.418	/	1211.063
=	-0.09

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.20

AIM Vaccine Co (HKSE:06660) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

AIM Vaccine Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of AIM Vaccine Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

AIM Vaccine Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AIM Vaccine Co Ltd (HKSE:06660) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

91 Jianguo Road, 25th Floor, Building A, Chaoyang, Beijing, CHN

Website

https://www.aimbio.com

AIM Vaccine Co Ltd is a top full-chain vaccine corporation in China with businesses covering the whole industrial chain ranging from research and development to manufacturing and commercialization. The Vaccine products include Recombinant HBV Vaccines, Freeze-dried Human Rabies Vaccine, Inactivated HAV Vaccines, Group A, C, Y, and W135 MPSV, Bivalent Inactivated HFRS Vaccine, and Mumps Vaccine. It generates all of its revenues in the PRC.

Executives

Shang Hai Xun Jing Qi Ye Guan Li Zhong Xin You Xian He Huo	2201 Interest of corporation controlled by you
Xi Zang Ying Feng Shi Ye You Xian Gong Si	2101 Beneficial owner
Yang Aihua	2201 Interest of corporation controlled by you
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Shang Yin Xing Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Zi Ben Guan Li Shen Zhen You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Shi Bei Lun Qu Guo You Zi Ben Yun Ying You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Bao Shui Qu Kong Gu You Xian Gong Si	2101 Beneficial owner
Chang Wei	2201 Interest of corporation controlled by you
Wang Aijun	2201 Interest of corporation controlled by you
China Merchants Bank Co., Ltd.	2201 Interest of corporation controlled by you
Zhang Kuo	2201 Interest of corporation controlled by you
Zhang Chong	2201 Interest of corporation controlled by you

AIM Vaccine Co Headlines

No Headlines